Literature DB >> 12764212

Risk factors for myocardial infarction during vacation travel.

Willem J Kop1, Ad Vingerhoets, Gert-Jan Kruithof, John S Gottdiener.   

Abstract

OBJECTIVES: Medical emergencies occur increasingly outside the usual health care area as a result of increased leisure and professional travel. Acute coronary syndromes are the leading cause of mortality during vacation. Vacation activities include physical and emotional triggers for myocardial infarction (MI). This study examines characteristics of vacation travel as risk factors for MI.
METHODS: Patients diagnosed with MI during vacation abroad (N = 92; age, 59.5 +/- 10.2; 79 men) were recruited through an emergency health insurance organization. Risk indicators for Vacation MI were examined and included: cardiovascular risk factors, psychosocial measures, and specific demands and activities related to vacation (eg, lodging accommodations, unfamiliar destination, mode of transportation, short-term planning). Vacation MI patients were compared with two reference groups: age-matched Vacation Controls with noncardiovascular medical emergencies (N = 67) and Hospital MI Controls, admitted in their usual health care area (N = 30).
RESULTS: Vacation MI occurred disproportionately (21.1%) during the first 2 days of vacation. Cardiovascular risk factors were more prevalent among Vacation MI patients than Vacation Controls (p values <.05) but not compared with Hospital MI Controls. Vacation MI occurred more often in patients with lower education (OR = 2.4, CI = 1.1-5.2) and those living with a spouse (OR = 2.6, CI = 1.0-7.1) than age-matched Vacation Controls. Compared with Hospital MI Controls, Vacation MI occurred more often among patients traveling by car versus other modes of transportation (OR = 2.5, CI = 1.0-6.1) and among patients staying in a tent or mobile home versus hotel (OR = 9.7, CI = 2.0-47.9).
CONCLUSION: Incidence of MI during vacation is highest during the first 2 days of vacation. Vacation activities such as adverse driving conditions and less luxurious accommodations may increase risk for MI. Individuals with known vulnerability for MI may therefore benefit from minimizing physical and emotional challenges specifically related to vacation travel.

Entities:  

Mesh:

Year:  2003        PMID: 12764212     DOI: 10.1097/01.psy.0000046077.21273.ec

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  6 in total

Review 1.  Travel medicine for the extreme traveler.

Authors:  David R Boulware
Journal:  Dis Mon       Date:  2006-08       Impact factor: 3.800

2.  Austrian Moderate Altitude Studies (AMAS): benefits of exposure to moderate altitudes (1,500-2,500 m).

Authors:  Wolfgang Schobersberger; Veronika Leichtfried; Michael Mueck-Weymann; Egon Humpeler
Journal:  Sleep Breath       Date:  2009-08-11       Impact factor: 2.816

3.  Vacationers Happier, but Most not Happier After a Holiday.

Authors:  Jeroen Nawijn; Miquelle A Marchand; Ruut Veenhoven; Ad J Vingerhoets
Journal:  Appl Res Qual Life       Date:  2010-02-10

4.  Coronary deaths during Midsummer festival in Finland: miseries of long, light nights.

Authors:  Simo Näyhä
Journal:  Eur J Epidemiol       Date:  2021-04-21       Impact factor: 8.082

5.  Effects of acute exposure to moderate altitude on vascular function, metabolism and systemic inflammation.

Authors:  Anne-Christin Stöwhas; Tsogyal D Latshang; Christian M Lo Cascio; Sina Lautwein; Katrin Stadelmann; Noemi Tesler; Lisa Ayers; Kaspar Berneis; Philipp A Gerber; Reto Huber; Peter Achermann; Konrad E Bloch; Malcolm Kohler
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

6.  Short Vacation Improves Stress-Level and Well-Being in German-Speaking Middle-Managers-A Randomized Controlled Trial.

Authors:  Cornelia Blank; Katharina Gatterer; Veronika Leichtfried; Doris Pollhammer; Maria Mair-Raggautz; Stefan Duschek; Egon Humpeler; Wolfgang Schobersberger
Journal:  Int J Environ Res Public Health       Date:  2018-01-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.